AGACell’s Principal Investigator, Dr. López Bran, Participates as a Speaker at the FUE ASIA Congress
Interest in the work of Spanish researcher López Bran aimed at putting an end to baldness has reached India. Research into a new therapy based on the use of stem cells to treat the most common type of baldness—caused by genetic factors—has been one of the main highlights of the FUE ASIA congress, held in […]
The end of baldness in Spain? A nurse reveals a study with ‘very promising’ results.
Baldness, or alopecia, is the excessive loss of hair from the scalp or other parts of the body. It occurs when the hair follicle shrinks and stops producing hair, or produces thinner hair, and it can be temporary or permanent. It is very common in men, and in some cases hair transplants are chosen as […]
Hair transplantation: effective and safe, without medication
Dr. López Bran, why do these anti-hair loss drugs raise concerns among the population, especially men? “Among the different options dermatologists have to address androgenetic alopecia, oral finasteride 1 mg, topical finasteride, and oral dutasteride 0.5 mg are surrounded by controversy due to the possible appearance of adverse side effects, which can be very serious […]
Entrepreneurship in Biotechnology: Leading with a Vision for the Next Decade
In biotechnology, leading a company means making decisions today whose true impact will only be visible many years from now. It is accepting that the most important return is not always measured in the next quarter, but in the next decade. Innovation in healthcare requires time, investment, and tolerance for failure. In both a BioTech […]
Marisa Berenguer, CEO of Ideeea Therapeutics: “AGAcell is the first proposal to combine allogeneic mesenchymal stem cells from a healthy external donor to treat androgenetic alopecia.”
Farmalider was founded in 1986 and, since its inception, has established itself as one of the leading innovators in health projects in Spain through the constant improvement of pharmaceutical products. The company has now decided to invest in biotechnology to expand its reach, and one of its new flagship projects, AGAcell, is being driven by […]
Mesenchymal stem cells and regeneration
Mesenchymal stem cells and regeneration Mesenchymal stem cells (MSCs) are stromal cells which self-renew and differentiate to mesodermal lineages. In addition, their capacity to enhance tissue restoration has made them become a central focus in regenerative applications. Their main positive effects are based on immunomodulation and paracrine factors involved in tissue homeostasis, angiogenesis, wound healing […]
Ideeea Therapeutics Selected Among the TOP15 Startups Transforming Spanish Biotechnology
Ideeea Therapeutics Selected Among the TOP15 Startups Transforming Spanish Biotechnology We are pleased to announce that Ideeea Therapeutics has been recognized by Diario El Referente as one of the 15 startups that are redefining the biotech landscape in Spain. This recognition highlights our contribution to the advancement of advanced therapies (ATMPs) through an innovative, rigorous, and patient-centered approach. Leading Innovation […]
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project The Spanish Association of Women Entrepreneurs (ASEME) has recognized Marisa Berenguer, CEO of Ideeea Therapeutics, as Entrepreneur of the Year for the development of AGAcell®, the first cell-based platform under investigation aimed at providing a treatment for androgenetic alopecia. Ideeea Therapeutics […]
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project The Spanish Association of Women Entrepreneurs (ASEME) has recognized Marisa Berenguer, CEO of Ideeea Therapeutics, as Entrepreneur of the Year for the development of AGAcell®, the first cell-based platform currently under investigation aimed at providing a treatment for androgenetic alopecia. Ideeea […]
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project
ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project The Spanish Association of Women Entrepreneurs (ASEME) has recognized Marisa Berenguer, CEO of Ideeea Therapeutics, as Entrepreneur of the Year for the development of AGAcell®, the first cell-based platform currently under investigation aimed at providing a treatment for androgenetic alopecia. Ideeea […]